Therefore, it is crucial to identify how IRF9 interacts with other coding and non-coding transcriptional regulators throughout signaling pathways in the tumor microenvironment to control the expression specifically of inflammation- and cancer-related interferon-stimulated genes and to develop advanced therapeutic strategies against these pathological processes. This evidence concerns the gene IRF9 and cancer.